A recent meta-analysis further confirmed reduced DAT activity in the caudate nucleus and putamen in PSP vs. PD and MSA-P, and in MSA-P vs. MSA-C (231). The gene discussed is SLC6A3; the disease is supranuclear palsy, progressive, 1.